BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:Prostate cancer imaging: from cell to man - John Kurhanewicz\, Pro
 fessor of Radiology and Biomedical Imaging\, Urology and Pharmaceutical Ch
 emistry\, Department of Radiology and Biomedical Imaging\, University of C
 alifornia\, San Francisco
DTSTART:20100526T103000Z
DTEND:20100526T111500Z
UID:TALK24731@talks.cam.ac.uk
CONTACT:Katrien Van Look
DESCRIPTION:More than many cancers\, prostate cancer requires accurate ima
 ging information to select the most appropriate treatment for individual p
 atients and for assessing response to therapy.  This is due to the patholo
 gic and biologic complexity of the human prostate and prostate cancer.  Th
 is complexity results in questions of whether and how to treat individual 
 prostate cancer patients.  Additionally\, this complexity demands state-of
 -the-art high spatial resolution multiparametric MR imaging and spectrosco
 py techniques to accurately assess disease status in individual patients. 
 Increasing numbers of published studies have shown that the ability to mee
 t these complex prostate cancer imaging needs requires a combination of ad
 vanced anatomic and functional imaging approaches\, including\; 1H MRSI\, 
 diffusion weighted imaging\, dynamic contrast imaging\, quantitative T2-ma
 pping\, and by performing the imaging exam on higher magnetic field streng
 th MR scanners.  Additionally\, an extraordinary new technique utilizing h
 yperpolarized 13C labeled metabolic substrates has the potential to revolu
 tionize the way we use MR imaging in the clinical management of prostate c
 ancer patients. In this lecture\, the current clinical status of these adv
 anced imaging techniques for the detection and characterization of prostat
 e cancer prior to and after therapy will be concisely reviewed with an emp
 hasis on the clinical utility of the resulting imaging information\, and t
 he obstacles that need to be over-come to establish advanced multiparametr
 ic prostate imaging as a routine clinical tool.
LOCATION:Cancer Research UK Cambridge Research Institute\, Lecture Theatre
END:VEVENT
END:VCALENDAR